News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Rafik H. Bishara, Technical Advisor

Advertisement

Articles by Rafik H. Bishara, Technical Advisor

Adopting the TAPA cargo security standards in the pharmaceutical industry

ByRafik H. Bishara, Technical Advisor,Susan Griggs, Eli Lilly and Company, Inc.
August 27th 2014

Securing your supply chain

Advertisement

Latest Updated Articles

  • Adopting the TAPA cargo security standards in the pharmaceutical industry
    Adopting the TAPA cargo security standards in the pharmaceutical industry

    Published: August 27th 2014 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies

2

The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection

3

Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies

4

Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial

5

Cutting Product Loss and Carbon Emissions in Pharma Supply Chains

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us